US expands use of Alexion rare disease therapy Soliris
admin 25th October 2017 Uncategorised 0Alexion’s rare disease therapy Soliris can now be used in the US to treat generalised myasthenia gravis in patients who are anti-acetylcholine receptor antibody-positive, offering this group the first new treatment option in more than 60 years.
More: US expands use of Alexion rare disease therapy Soliris
Source: News